Sean Bohen, Olema president & CEO
Olema gives small update to breast cancer drug at center of layoffs, 2021 data leak
Olema Pharmaceuticals is out with more data on its investigational breast cancer drug, for which it shed 25% of its workforce two months ago to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.